Since we observed that MIF is overexpressed in TNBC and enhance breast cancer growth and migration in vitro and in vivo, we evaluated the anticancer potency of a small-molecule chemical inhibitor of MIF to inhibit the proliferation and progression of TNBC. Here, MIF is linked to breast cancer.